Galectin Therapeutics Inc.
USD3.85
-0.15 (-3.88%)
CEO
Joel Lewis
IPO Date
2002-09-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.04
Prev. Close
$4.00
Day Low
$3.83
Day High
$4.13
52W Low
$2.03
52W High
$7.13
Market Cap
$0.25B
Volume
0.31M
| 16,250 |
| $5.13 |
| 16 Jul 2026 | Jamil Khurram | Chief Medical Officer | M-Exempt | Disposed | 16,250 | $3.04 |
| 30 Jun 2026 | Shlevin Harold H. | director | M-Exempt | Acquired | 7,732 | $1.23 |
| 30 Jun 2026 | Shlevin Harold H. | director | S-Sale | Disposed | 7,732 | $5.00 |
| 30 Jun 2026 | Shlevin Harold H. | director | M-Exempt | Acquired | 22,268 | $1.23 |
| 30 Jun 2026 | Shlevin Harold H. | director | S-Sale | Disposed | 22,268 | $5.04 |
| 30 Jun 2026 | Shlevin Harold H. | director | M-Exempt | Disposed | 7,732 | $1.23 |
| 30 Jun 2026 | Shlevin Harold H. | director | M-Exempt | Disposed | 22,268 | $1.23 |
| 30 Jun 2026 | Jamil Khurram | Chief Medical Officer | M-Exempt | Acquired | 2,037 | $2.20 |